Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Pharmacy Licensing topic
No spam. Unsubscribe anytime.
Commission approves new and relocated pharmacy licenses, denies several out‑of‑state applications
Summary
Connecticut’s Commission of Pharmacy approved a batch of new licenses, relocations and remodels and voted to deny a set of nonresident pharmacy applications, citing application deficiencies and pending drug‑control matters.
Get email alerts on the Pharmacy Licensing topic
No spam. Unsubscribe anytime.
The Connecticut Department of Consumer Protection’s Commission of Pharmacy voted to approve several new pharmacy licenses, store relocations and remodels and to deny a number of nonresident pharmacy applications during its public meeting.
The commission approved a new in‑state pharmacy application for Pharmacare USA (agenda typo noted: appears as "Pharmacare" on the agenda) and voted to approve Greenview Pharmacy LLC’s relocation from 13 North Water Street to 244 Mill Street in Greenwich. The body also approved remodels (including Bernie’s Pharmacy, 615 Howard Ave., New Haven) and licensed operations for CPH Hartford LLC d/b/a Vital Care (East Hartford) and Costco Wholesale Corporation (South Windsor). Each item passed on motions presented at the meeting with the board calling for aye votes and recording the motions as "so moved." The meeting transcript records the standard roll call confirmations but does not list recorded roll‑call vote tallies by individual commissioner names for these motions.
Separately, the commission considered nonresident pharmacy applications and rejected several new out‑of‑state applicants that did not provide required detail or appeared to mischaracterize services (for example, indicating sterile compounding capability where it did not appear to exist). The board flagged Premium Healthcare (Miami) and AP Max Incorporated (South End Pharmacy, Houston) for denial; the transcript shows the denials were grounded in application deficiencies and, in some cases, active drug‑control referrals.
Why it matters: the approvals expand retail and institutional pharmacy access in Connecticut, while the denials signal heightened scrutiny of nonresident pharmacies and coordination with drug control investigations. Commissioners said the denials are intended to protect Connecticut patients and ensure out‑of‑state providers meet state standards before accepting prescriptions for Connecticut residents.
Votes at a glance
- Pharmacare USA (new in‑state pharmacy): motion to approve accepted; outcome: approved. - Greenview Pharmacy LLC (relocation to 244 Mill Street, Greenwich): motion to approve accepted; outcome: approved. - Bernie’s Pharmacy (remodel, 615 Howard Ave., New Haven): motion to approve accepted; outcome: approved. - CPH Hartford LLC d/b/a Vital Care (East Hartford): motion to approve accepted; outcome: approved. - Costco Wholesale Corporation (South Windsor): motion to approve accepted; outcome: approved. - Multiple nonresident pharmacy applications reviewed; a subset were approved with additional documentation; a separate list of new nonresident applicants was denied for deficiencies; outcome: denied (listed applicants including Premium Healthcare and AP Max Incorporated).
Background and process details: commissioners confirmed applicants’ attestations on matters such as sterile compounding, whether point‑of‑sale or other computer systems with protected health information would sit outside licensed pharmacy areas, and compliance with local and state building codes. Board staff indicated some denials stemmed from specialty pharmacies checking “sterile compounding” when their operations did not match that selection; staff said they will pursue application clarifications and may update forms to reduce future mismatches.
Ending: Board administrators and commissioners said they will follow up on denied applications and coordinate with the Department’s drug‑control unit on cases where complaints or investigations exist.

